Mark A. Kay

Mark A. Kay

Directeur/Membre du Conseil chez
Genevant Sciences Corp.
68 ans
Consumer Services
Health Technology
Commercial Services

Profil

Mark A. Kay is the founder of Voyager Therapeutics, Inc. (2013), American Society of Gene & Cell Therapy (2005), and LogicBio Therapeutics, Inc. (2014).
He held the title of President at American Society of Gene & Cell Therapy from 2005 to 2006 and the title of Independent Director at LogicBio Therapeutics, Inc. from 2016 to 2022.
Currently, he is an Independent Director at Genevant Sciences Corp.
since 2018 and a Professor & Head-Human Gene Therapy Division at Stanford University School of Medicine since 1998.
Dr. Kay received his undergraduate degree from Michigan State University and his doctorate from Case Western Reserve University.

Postes actifs de Mark A. Kay

SociétésPosteDébut
Corporate Officer/Principal 01/01/1998
Directeur/Membre du Conseil 19/11/2018

Anciens postes connus de Mark A. Kay

SociétésPosteFin
LOGICBIO THERAPEUTICS, INC. Fondateur 16/11/2022
Fondateur 01/01/2006
VOYAGER THERAPEUTICS, INC. Fondateur -
Voir l'expérience en détail de Mark A. Kay

Formation de Mark A. Kay

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

36

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Mark A. Kay
🔇